<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) is defined by the presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPL), associated with <z:mp ids='MP_0005048'>thrombosis</z:mp> or recurrent <z:hpo ids='HP_0005268'>spontaneous abortions</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>APS can occur alone or secondary to other conditions, especially associated to inflammatory systemic <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Among the neurological manifestations associated with aPL, only <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> is recognized by the actual classification criteria for APS </plain></SENT>
<SENT sid="3" pm="."><plain>Other neurological manifestations have been, however, repeatedly reported in case studies of APS patients </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0002315'>Headache</z:hpo>, and especially <z:hpo ids='HP_0002076'>migraine</z:hpo>, was commonly reported in APS patients and is one of the classical features described by Hughes as related to aPL, but studies failed to confirm this association </plain></SENT>
<SENT sid="5" pm="."><plain>We studied retrospectively the association between <z:hpo ids='HP_0002315'>headache</z:hpo> syndromes and aPL in 428 patients with inflammatory <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue diseases</z:e> admitted in the Neurology and Internal Medicine Departments of Colentina Hospital-Bucharest </plain></SENT>
<SENT sid="6" pm="."><plain>We found that <z:hpo ids='HP_0002076'>migraine</z:hpo> alone, not <z:hpo ids='HP_0002315'>headache</z:hpo> of <z:hpo ids='HP_0000001'>all</z:hpo> types, is significantly associated with aPL in patients with systemic <z:e sem="disease" ids="C0021053" disease_type="Disease or Syndrome" abbrv="">immune disease</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>We studied the presence of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in patients with <z:hpo ids='HP_0002315'>headache</z:hpo> and aPL </plain></SENT>
<SENT sid="8" pm="."><plain>In SLE patients, <z:hpo ids='HP_0002315'>headache</z:hpo> (<z:hpo ids='HP_0000001'>all</z:hpo> types) is significantly associated with positive titers of aPL, and cerebral ischemic lesions are significantly encountered </plain></SENT>
<SENT sid="9" pm="."><plain>Even if both <z:hpo ids='HP_0002076'>migraine</z:hpo> and aPL are conditions with high frequency in patients with immune <z:e sem="disease" ids="C0442893" disease_type="Disease or Syndrome" abbrv="">systemic disease</z:e> and their association may be coincidental, the presence of ischemic lesions in patients showing this association suggests the need to define a sub-group at risk, for whom <z:hpo ids='HP_0002315'>headache</z:hpo> can be a marker and <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> can be discussed </plain></SENT>
</text></document>